ColleenSusanneDelaneyMD
Pediatric Hematology & Oncology • Seattle, WAAssistant Professor of Pediatrics, University Wash
Dr. Delaney is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
825 Eastlake Ave E
Seattle, WA 98109Phone+1 206-288-1000
Education & Training
University of WashingtonFellowship, Pediatric Hematology/Oncology, 1999 - 2002
University of California (San Francisco)Residency, Pediatrics, 1996 - 1999
Harvard Medical SchoolClass of 1996
Certifications & Licensure
CA State Medical License 1998 - Present
WA State Medical License 2001 - 2026- American Board of Pediatrics Pediatric Hematology-Oncology
Clinical Trials
- A Pilot Study to Evaluate the Co-Infusion of Ex Vivo Expanded Cord Blood Cells With an Unmanipulated Cord Blood Unit in Patients Undergoing Cord Blood Transplant for Hematologic Malignancies Start of enrollment: 2006 Apr 01
- Umbilical Cord Blood Transplant, Cyclophosphamide, Fludarabine, and Total-Body Irradiation in Treating Patients With Hematologic Disease Start of enrollment: 2005 Nov 18
- Donor Umbilical Cord Blood Transplant in Treating Patients With Hematologic Cancer Start of enrollment: 2008 Jun 25
- Join now to see all
Publications & Presentations
PubMed
- 289 citationsSignificance of minimal residual disease before myeloablative allogeneic hematopoietic cell transplantation for AML in first and second complete remissionRoland B. Walter, Sarah A. Buckley, John M. Pagel, Brent L. Wood, Barry E. Storer
Blood. 2013-09-05 - 128 citationsExpansion of primitive human hematopoietic stem cells by culture in a zwitterionic hydrogelTao Bai, Jianqiang Li, Andrew Sinclair, Suzan Imren, Fabiola Merriam
Nature Medicine. 2019-10-01 - 198 citationsEx vivo expansion of human hematopoietic stem and progenitor cellsAnn Dahlberg, Colleen Delaney, Irwin D. Bernstein
Blood. 2011-06-09
Journal Articles
- Disability Related to Chronic Graft-Versus-Host Disease After Alternative Donor Hematopoietic Cell TransplantationMary E Flowers, Brenda M Sandmaier, Rachel B Salit, Colleen Delaney, Filippo Milano, Stephanie J Lee, Haematologica
Abstracts/Posters
- Cord Blood Transplantation Is an Effective Treatment Option in Patients with Myelodysplastic and Myeloproliferative SyndromesColleen Delaney, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/7/2019
- Comparison of Outcomes between HSCT Donor Sources for Pediatric Patients with Hematologic MalignanciesColleen Delaney, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/9/2019
- High Incidence of Herpes Zoster after Cord Blood Hematopoietic Cell Transplant Despite Longer Duration of Antiviral ProphylaxisColleen Delaney, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/9/2019
- Join now to see all
Press Mentions
Nohla Therapeutics Announces Hiring of Dr. Sarah Noonberg as Chief Medical Officer and Appointment of Dr. Colleen Delaney as Chief Scientific OfficerJuly 30th, 2018
Fred Hutch Tip Sheet: Breast Cancer, Skin Cells as a Cancer Repair Mechanism, HIV Prevention Study, Air Pollution Risk and MoreAugust 24th, 2017
Kleberg Foundation Grant to Support Clinical Trial for Leukemia PatientsAugust 17th, 2017- Join now to see all
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
